A phase II, single-dose, open-label study to investigate the safety and efficacy of OTL38 injection for intraoperative imaging of folate receptor-alpha positive ovarian cancer

Objective: OTL38 is a folate ligand conjugated with an indole-cyanine green dye. The objectives of this trial were to assess the efficacy and safety of OTL38 in detecting folate receptor-alpha (FRα+) ovarian cancer during surgery.